These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28000414)
1. Identification of CLK1 Inhibitors by a Fragment-linking Based Virtual Screening. Walter A; Chaikuad A; Loaëc N; Preu L; Knapp S; Meijer L; Kunick C; Koch O Mol Inform; 2017 Apr; 36(4):. PubMed ID: 28000414 [TBL] [Abstract][Full Text] [Related]
2. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease. Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585 [TBL] [Abstract][Full Text] [Related]
3. New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis. Tazarki H; Zeinyeh W; Esvan YJ; Knapp S; Chatterjee D; Schröder M; Joerger AC; Khiari J; Josselin B; Baratte B; Bach S; Ruchaud S; Anizon F; Giraud F; Moreau P Eur J Med Chem; 2019 Mar; 166():304-317. PubMed ID: 30731399 [TBL] [Abstract][Full Text] [Related]
4. 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A. Falke H; Chaikuad A; Becker A; Loaëc N; Lozach O; Abu Jhaisha S; Becker W; Jones PG; Preu L; Baumann K; Knapp S; Meijer L; Kunick C J Med Chem; 2015 Apr; 58(7):3131-43. PubMed ID: 25730262 [TBL] [Abstract][Full Text] [Related]
5. A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor. Aubol BE; Fattet L; Adams JA FEBS J; 2021 Jan; 288(2):566-581. PubMed ID: 32359191 [TBL] [Abstract][Full Text] [Related]
6. Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment. Zu M; Li C; Fang JS; Lian WW; Liu AL; Zheng LS; Du GH Molecules; 2015 Nov; 20(11):19735-47. PubMed ID: 26540031 [TBL] [Abstract][Full Text] [Related]
7. Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. Bullock AN; Das S; Debreczeni JE; Rellos P; Fedorov O; Niesen FH; Guo K; Papagrigoriou E; Amos AL; Cho S; Turk BE; Ghosh G; Knapp S Structure; 2009 Mar; 17(3):352-62. PubMed ID: 19278650 [TBL] [Abstract][Full Text] [Related]
8. In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach. Shafique S; Bibi N; Rashid S J Theor Biol; 2016 Jan; 388():72-84. PubMed ID: 26493360 [TBL] [Abstract][Full Text] [Related]
9. Nuclear protein kinase CLK1 uses a non-traditional docking mechanism to select physiological substrates. Keshwani MM; Hailey KL; Aubol BE; Fattet L; McGlone ML; Jennings PA; Adams JA Biochem J; 2015 Dec; 472(3):329-38. PubMed ID: 26443864 [TBL] [Abstract][Full Text] [Related]
10. Novel CLK1 inhibitors based on N-aryloxazol-2-amine skeleton - A possible way to dual VEGFR2 TK/CLK ligands. Murár M; Dobiaš J; Šramel P; Addová G; Hanquet G; Boháč A Eur J Med Chem; 2017 Jan; 126():754-761. PubMed ID: 27940419 [TBL] [Abstract][Full Text] [Related]
11. Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members. Prak K; Kriston-Vizi J; Chan AW; Luft C; Costa JR; Pengo N; Ketteler R Biochemistry; 2016 Jan; 55(3):608-17. PubMed ID: 26701387 [TBL] [Abstract][Full Text] [Related]
12. Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype. Walter A; Chaikuad A; Helmer R; Loaëc N; Preu L; Ott I; Knapp S; Meijer L; Kunick C PLoS One; 2018; 13(5):e0196761. PubMed ID: 29723265 [TBL] [Abstract][Full Text] [Related]
13. Regulation of influenza A virus mRNA splicing by CLK1. Artarini A; Meyer M; Shin YJ; Huber K; Hilz N; Bracher F; Eros D; Orfi L; Keri G; Goedert S; Neuenschwander M; von Kries J; Domovich-Eisenberg Y; Dekel N; Szabadkai I; Lebendiker M; Horváth Z; Danieli T; Livnah O; Moncorgé O; Frise R; Barclay W; Meyer TF; Karlas A Antiviral Res; 2019 Aug; 168():187-196. PubMed ID: 31176694 [TBL] [Abstract][Full Text] [Related]
14. Disordered protein interactions for an ordered cellular transition: Cdc2-like kinase 1 is transported to the nucleus via its Ser-Arg protein substrate. George A; Aubol BE; Fattet L; Adams JA J Biol Chem; 2019 Jun; 294(24):9631-9641. PubMed ID: 31064840 [TBL] [Abstract][Full Text] [Related]
15. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Fedorov O; Huber K; Eisenreich A; Filippakopoulos P; King O; Bullock AN; Szklarczyk D; Jensen LJ; Fabbro D; Trappe J; Rauch U; Bracher F; Knapp S Chem Biol; 2011 Jan; 18(1):67-76. PubMed ID: 21276940 [TBL] [Abstract][Full Text] [Related]
17. Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study. Shahroz MM; Sharma HK; Altamimi ASA; Alamri MA; Ali A; Ali A; Alqahtani S; Altharawi A; Alabbas AB; Alossaimi MA; Riadi Y; Firoz A; Afzal O Molecules; 2022 Feb; 27(4):. PubMed ID: 35208955 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors. Schmitt C; Kail D; Mariano M; Empting M; Weber N; Paul T; Hartmann RW; Engel M PLoS One; 2014; 9(3):e87851. PubMed ID: 24676346 [TBL] [Abstract][Full Text] [Related]
19. Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945. Lee JY; Yun JS; Kim WK; Chun HS; Jin H; Cho S; Chang JH Biomed Res Int; 2019; 2019():6125068. PubMed ID: 31531359 [TBL] [Abstract][Full Text] [Related]
20. 5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency. ElHady AK; El-Gamil DS; Chen PJ; Hwang TL; Abadi AH; Abdel-Halim M; Engel M Molecules; 2021 Feb; 26(4):. PubMed ID: 33668683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]